Gerardo TurcattiSenior scientific level (R&D) with extensive experience in the management of multidisciplinary technological projects. Prof. Gerardo Turcatti, directs the academic technological platform, Biomolecular Screening Facility (BSF) at the EPFL he created in 2006. In the framework of the NCCR-Chemical Biology, he is project leader of the program ACCESS (An Academic Chemical Screening Platform for Switzerland). Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company that developed high throughput DNA sequencing technologies currently owned by Illumina and used in the ‘Next Generation Sequencing’ instruments. Prior to this experience, Prof. Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies with extensive expertise in several Chemical Biology-related disciplines such as Drug Screening, Chemical Biology, Bio-analytical Chemistry, DNA and Protein Chemistry. Prof. Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry from the EPFL where he received the award for the best doctoral thesis of the year.
Pablo Rivera FuentesPablo Rivera-Fuentes was born in 1984 in Mexico City. He received a BSc (2008) degree in chemical engineering from the National Autonomous University of Mexico. He obtained his MSc (2009) and PhD (2012) degrees in chemistry from ETH Zurich, working under the supervision of Prof. François Diederich. His dissertation was awarded the ETH Medal in 2013. Funded by the Swiss National Science Foundation (SNSF), he carried out postdoctoral research at Massachusetts Institute of Technology with Prof. Stephen J. Lippard (2012-2014). He subsequently worked at the University of Oxford with Prof. Harry L. Anderson (Department of Chemistry) and Prof. Christian Eggeling (Weatherall Institute of Molecular Medicine). He started his independent career as non-tenure-track assistant professor at ETH Zurich in October, 2015, and became tenure-track assistant professor of chemical biology at EPFL in August, 2019.
Marwan Muhammad Ahmed AbdellahMarwan Abdellah, a self-motivated engineer born in Cairo, Egypt in 1987. He received his B.Sc. and M.Sc. degrees in Biomedical Engieering with distinction with honor from the Systems & Biomedical Engineering Department (SBME), Faculty of Engineering at Cairo University in 2009 and 2012 respectively. After graduation, he worked as a Research Engineer at IBE Technologies's R&D Department in a 4D ultrasound machines project. Then he moved to work as an Associate Software Engineer at the Biomedical Department in Symbyo Technologies. Afterwards, he joined the Multimedia Laboratory in the Swiss Federal Institute of Technology, Lausanne (EPFL) to conduct a research on H.264 & Reconfigurable Video Coding. Currently, he is working as a Scentific Visualization Engineer in the Blue Brain Project led by Prof. Henery Markram in the Brain Mind Institute at the Swiss Federal Institute of Technology, Lausanne (EPFL). Along with his professional career, Abdellah worked as an instructor at NILES (National Institute of Laser Enhanced Science) in Cairo University. He taught two courses in the areas of Computer Graphics and High Performance Computing. He focused in his M.Sc. thesis research on implementing high performance volume rendering techniques for large scale medical data on heterogeneous platforms. He succeeded in constructing a high performance Fourier Volume Render running entirely on CUDA-enable GPUs. Among his research intersets are High Perfromance Computing, Heterogenous Comuting, Visualization, Scalable Rendering, Computer Graphics & Modelling, Medical Image Processing, Video Processing & Reconfigurable Video Coding, Abdellah has been awarded a graphics card from NVIDIA during attending a workshop in High Performance Computing at the Intenational Center of Theoritical Physics (ICTP) in Trieste, Italy. His graduation project was honored by ITIDA and Egyptian Ministres of Telecommunications & Higher Education during a celebration organized by ITIDA in March 2010.
